Affini-T Therapeutics is based in Boston, Massachusetts. It has raised $175M in total funding. Latest round: Seed.
Affini-T Therapeutics is based in Boston, Massachusetts. Affini-T Therapeutics has raised $175M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed announced in March 2022. The round record for Affini-T Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Vida Ventures, Leaps by Bayer, Humboldt Fund, The Parker Institute for Cancer Immunotherapy, Catalio Capital Management, Agent Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Affini-T Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
The investor deck Affini-T Therapeutics used to raise — 2022, Series B, 24-slide deck is broken down slide by slide, including the slides it leads with and the questions it leaves open.
Company funding database · Investor directory · Founder database · Mega-rounds 2026